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Abstract
Background: Autopsy studies are the gold standard for determining cause-of-death and can inform on improved
diagnostic strategies and algorithms to improve patient care. We conducted a cross-sectional observational autopsy
study to describe the burden of respiratory tract infections in inpatient children who died at the University
Teaching Hospital in Lusaka, Zambia.
Methods: Gross pathology was recorded and lung tissue was analysed by histopathology and molecular
diagnostics. Recruitment bias was estimated by comparing recruited and non-recruited cases.
Results: Of 121 children autopsied, 64 % were male, median age was 19 months (IQR, 12–45 months). HIV status
was available for 97 children, of whom 34 % were HIV infected. Lung pathology was observed in 92 % of cases.
Bacterial bronchopneumonia was the most common pathology (50 %) undiagnosed ante-mortem in 69 % of cases.
Other pathologies included interstitial pneumonitis (17 %), tuberculosis (TB; 8 %), cytomegalovirus pneumonia (7 %)
and pneumocystis Jirovecii pneumonia (5 %). Comorbidity between lung pathology and other communicable and
non-communicable diseases was observed in 80 % of cases. Lung tissue from 70 % of TB cases was positive for
Mycobacterium tuberculosis by molecular diagnostic tests. A total of 80 % of TB cases were comorbid with
malnutrition and only 10 % of TB cases were on anti-TB therapy when they died.
Conclusions: More proactive testing for bacterial pneumonia and TB in paediatric inpatient settings is needed.
Keywords: Autopsy, Post mortem, Children, Zambia, Africa, Tuberculosis, Pneumonia, Cytomegalovirus,
Pneumocystis Jirovecii pneumonia
Background
Global Burden of Disease study estimates suggest that,
for children, bacterial pneumonia is the leading single
cause of death, responsible for 23 % of deaths in children
aged between 27 days and 5 years of age [1]. Respiratory
pathology may also play a role in additional deaths, as
bacterial, fungal or viral lung infections may underlie other
major causes of death, including infections such as malaria
or diarrhoeal disease, as well as non-communicable
diseases such as malnutrition [2–4]. Determining the aeti-
ology of childhood respiratory deaths in the African
context is particularly challenging – symptoms are non-
specific, obtaining specimens for microbiological analysis
from infants and young children ante mortem is difficult,
and in the low-resource settings laboratory services cannot
provide a thorough microbiological work-up combining
culture with the latest multiplex molecular diagnostics
[4, 5]. It is hence extremely difficult for the attending phys-
ician to differentiate between bacterial, mycobacterial, fun-
gal or viral aetiologies [6, 7]. The non-specific symptoms of
respiratory infections also contribute to the inaccuracy of
verbal autopsy studies, which rely on interviewing relatives
or the attending physician [8].
The gold-standard for determining cause-of-death is
anatomical post mortem followed by histopathological
examination of selected tissues [9]. Post mortem studies
have been rarely undertaken in the African context
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because they are expensive and difficult to implement,
requiring highly skilled personnel and sophisticated in-
frastructure, and because they are culturally unpalatable,
particularly with respect to children [4, 10, 11]. Further-
more, the results of autopsy studies are often overlooked
by epidemiologists due to the relatively small sample
sizes compared to larger and easier to implement sur-
veys of clinical records and verbal autopsy studies. How-
ever, when autopsy studies have been undertaken, they
often yield surprising results. In 2002, we conducted a
landmark autopsy study of 264 Zambian paediatric deaths
[12], which influenced World Health Organization policy
with respect to the burden of paediatric tuberculosis (TB),
and led to studies to treat Pneumocystis Jirovecii pneumo-
nia (PCP) in HIV-infected children [13].
The decade that followed has seen the roll out of anti-
retroviral therapy (ART) and prevention of mother-to-child
transmission programmes. We conducted a prospective
autopsy study to describe the histopathological and micro-
biological findings derived from the examination of lungs at
post mortem among inpatient children who died at the
University Teaching Hospital (UTH), Lusaka, Zambia.
Methods
Study design
We undertook a cross-sectional autopsy study of in-
patient paediatric deaths at UTH, Zambia’s national re-
ferral centre, to determine the burden of respiratory
pathology among children dying at the hospital. All chil-
dren < 15 years of age who died in the inpatient wards at
UTH were eligible for inclusion in the study. Necropsy
restricted to the chest cavity was performed. Autopsy
findings and outcome data on respiratory causes-of-
death were compared with the cause-of-death given by
the attending physician. Baseline age and sex of all in-
patient paediatric deaths during the recruitment period
was extracted from hospital mortality records to allow a
rough estimate of how the study group might be repre-
sentative of all paediatric mortalities within the hospital.
Recruitment and consent
The recruitment process takes several hours and in-
volves counselling the relatives and talking about the
child who has died, before then introducing the idea of
the autopsy investigation and explaining the purpose
and rationale of the study. Due to time constraints, it
was not possible to approach the relatives of all children
who died during the study period. The recruiting clinical
officer (CC) worked Monday to Friday and so the rela-
tives of children who died between Friday afternoon and
Sunday morning were unlikely to be approached to take
part in the study. In Zambia, there is a cultural require-
ment that there be minimal delay in burying children.
After being alerted to deaths by the attending physician,
our multi-lingual clinical officer would approach the rel-
atives to offer counselling, introducing them to the study
in their native language and providing them with written
information sheets (available in English, Chi-Nyanja and
Chi-Bemba) explaining the purpose of the study. The at-
tending relatives were given the opportunity to consult
with family elders and to ask any questions they might
have, and reasons for refusing consent were recorded.
Consenting families were given a payment of $10 to
compensate for the delayed release of the deceased for
burial. The HIV status of the children in this study is
taken from either neonatal PCR testing (in children
under 18 months of age) and/or standard serology test-
ing in accordance with Zambian national guidelines in
children aged 18 months and older. Ethical approval for
the study was granted by the University of Zambia Bio-
medical Research Ethics Committee.
Autopsy examination and sampling
One of two consultant pathologists (VM and AS) under-
took a limited necropsy examination within 18 hours after
death, examining the lungs, intrathoracic lymph nodes,
heart, kidneys, pancreas, spleen and liver. Gross pathology
was recorded and photographed, organs weighed and dis-
sected, with lung samples taken for histopathology and
aseptically for cryopreservation (stored at −80 °C), employ-
ing strict safety procedures as previously described [14].
Samples were obtained from all five lobes guided by gross
pathology. In the absence of gross pathology a representa-
tive specimen was sampled.
Histopathology
Histopathologists, blinded to clinical data, performed
haematoxylin and eosin, silver methenamine, periodic acid-
Schiff and Zeihl–Neelsen stains as previously described
[14]. Pathological findings were defined as described
[14, 15]. Post mortem diagnoses were based on a com-
posite of gross pathology and histopathology. Cultures
were not undertaken as the UTH TB lab had insufficient
capacity to culture TB from tissue specimens within the
timeframe of study commencement, and also because a
negative culture does not exclude TB disease at autopsy.
Zeihl–Neelsen stains were undertaken on all suspected
TB cases.
Molecular analysis
Cryopreserved lung tissue was analysed with the Xpert
MTB/RIF assay as previously described [14]. This cart-
ridge based molecular diagnostic test detects Mycobac-
terium tuberculosis (M.tb) complex DNA and rifampicin
resistance, a reasonable proxy marker of multi-drug
resistant-TB [16, 17]. For non-TB mycobacteria (NTM)
analysis, DNA was extracted from cryopreserved lung
tissue using the ‘E0101 DNA extraction kit’, and screened
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with the ‘PowerChek™ MTB/NTM Real-time PCR Kit’
(both supplied by Kogene, South Korea), in accordance
with manufacturer's instructions. This internally controlled
Real-Time PCR assay uses a generic pan-mycobacteria
probe (target 16S‐23S rRNA internal transcribed spacer
(ITS) region) and an M.tb specific probe(target IS6110) to
differentiate M.tb from NTM.
Data management and statistical analysis
We undertook double-data entry using Epidata and
exported cleaned datasets for analysis in SPSS version
21. Point prevalences were weighted based on the age
distribution and sex of the population of deaths at the
hospital as previously described [14].
Results
Case recruitment and descriptives
During the study period (August 2011 to June 2014)
there were a total of 3725 deaths among paediatric ad-
missions under 15 years of age. The recruiting clinical
officer approached 1471 families and obtained consent
for participation in the study from 121 families (Fig. 1).
The main reasons for refusing consent were time con-
straints on taking the child for burial and loss to follow-
up after agreeing to consult with family (Fig. 1). Of 121
children autopsied, 60 % (73/121) of cases were male,
median age was 19 months (IQR, 12–45 months), and
35 % (34/96) of children were HIV infected (Table 1).
ART status was determined for 24 cases, of which 63 %
(15) were on ART when they died. Overall, 12 % (15/121)
of children were receiving anti-TB therapy. Comparing
age and sex between study and non-study mortalities, we
found that the age distribution of participants in our study
was significantly older and that the percentage of male
children was higher (60 %, 73/121) than among non-study
deaths (50 %, 1810/3604; P = 0.029; Table 1). The median
duration of stay in hospital was 2 days (IQR, 1–6 days).
Lung pathologies and stratification by HIV status
Lung pathology was observed in 92 % (111/121) of cases
(Table 2). Bronchopneumonia was the most common
finding, diagnosed in 50 % (60/121) of cases, followed by
interstitial pneumonitis in 17 % (20/121). TB was de-
tected in 8 % (10/121) of all deaths (9 pulmonary and 1
extrapulmonary), and was two-fold more prevalent in
HIV-infected children, although within the limits of the
sample this was not significant (P = 0.15). Furthermore,
infections that are commonly associated with HIV, such
as cytomegalovirus pneumonia, pneumocystis Jirovecii
pneumonia and candidiasis, were not more prevalent
among HIV-infected children, within the limits of the
available sample (Table 2). Adjusting for recruitment
bias did not significantly affect the distribution of lung
pathologies (Table 2).
Comparison between lung pathology and diagnosis given
by the attending physician
We identified comorbidity between two or more commu-
nicable and non-communicable diseases in 80 % (97/121)
of cases (Table 3). Malnutrition (defined broadly as a com-
posite of Kwashiorkor/Protein Energy Malnutrition or
Marasmus) was the major co-morbidity with 93 % (57/61)
of malnourished children having a comorbidity. Among
non-malnourished children, comorbidity was observed in
67 % (40/60) of cases (Table 3). Among the 111 children
with lung pathology, the diagnoses given by the attending
Fig. 1 Recruitment flow diagram
Bates et al. BMC Medicine  (2016) 14:99 Page 3 of 9
physician indicated a range of possible comorbid condi-
tions, with both communicable and non-communicable
diseases (Table 3). Malnutrition was the predominant co-
morbidity, present in 50 % (56/111) of cases with lung
pathology, and was the predominant comorbidity for the
five most prevalent lung pathologies: bronchopneumonia,
interstitial pneumonitis, TB, CMV pneumonia and PCP
(Table 3). Lung pathology was observed in 100 % (15/15)
of children diagnosed with other non-communicable dis-
eases including cancer, heart disease and developmental
disorders (Table 3).
Among 59 children diagnosed with histopathologically
confirmed pneumonia, only 31 % (18/59) were diagnosed
as having pneumonia ante mortem. Other common ante
mortem diagnoses among histopathologically confirmed
pneumonia cases included sepsis (22 %, 13/59) and acute
diarrhoea and dehydration (27 %, 16/59; Table 3). Intersti-
tial pneumonitis presented with a range of comorbidities,
including acute diarrhoea and dehydration (35 %, 7/20),
pneumonia, sepsis, meningitis and malaria (each 15 %, 3/
20). Of 10 cases of histopathologically confirmed TB in-
fection, just 40 % (4/10) were diagnosed ante mortem
(Table 3), with only one case having initiated anti-TB ther-
apy before they died (Table 4). The other comorbid diag-
noses with confirmed TB were pneumonia (40 %, 4/10),
sepsis (20 %, 2/10) and meningitis (30 %, 3/10) (Table 3).
CMV pneumonia was diagnosed in cases with gastrointes-
tinal symptoms, and PCP was diagnosed in cases with
both gastrointestinal or central nervous system symptoms,
in addition to respiratory symptoms (Table 3). Of four
children on anti-TB therapy when they died, none had TB
pathology detected at post mortem.
Molecular analysis of lung tissue
The Xpert MTB/RIF assay detected rifampicin-sensitive
TB in 30 % (3/10) of lung tissue specimens in which
there was histopathological evidence of pulmonary TB
infection (Table 4). In addition, the Xpert MTB/RIF
assay was positive in 30 % (33/111) of cases in which
there was no histopathological evidence of TB infection,
including three cases of bronchopneumonia in which
Table 2 Lung pathology findings
Non-weighted Weighted for age and sex
Overall HIV uninfected HIV Infected HIV status unknown Overall
(n = 121) (n = 62) (n = 34) (n = 25) (n = 121)
Count (%) Count (%) Count (%) Count (%) Count (%, SE)
Lung pathology 111 (92 %) 53 (86 %) 34 (100 %) 24 (96 %) 112 (93 %, 2.4)
Bronchopneumonia 60 (50 %) 28 (45 %) 16 (47 %) 16 (64 %) 52 (43 %, 4.5)
Interstitial pneumonitis 20 (17 %) 9 (15 %) 7 (21 %) 4 (16 %) 21 (17 %, 3.4)
Tuberculosis (All forms) (PTB and/or EPTB) 10 (8 %) 4 (6 %) 5 (15 %) 1 (4 %) 11 (9 %, 2.6)
EPTB 1 (1 %) 0 (0 %) 1 (3 %) 0 (0 %) 1 (1 %, 0.8)
PTB 9 (7 %) 4 (6 %) 4 (12 %) 0 (0 %) 10 (8 %, 2.5)
Cytomegalovirus pneumonia 8 (7 %) 4 (6 %) 3 (9 %) 1 (4 %) 10 (9 %, 2.5)
Pneumocystis Jirovecii Pneumonia 6 (5 %) 2 (3 %) 3 (9 %) 1 (4 %) 13 (11 %, 2.9)
Pulmonary oedema 6 (5 %) 5 (8 %) 0 (0 %) 1 (4 %) 4 (4 %. 1.7)
Candidiasis 3 2 %) 3 (5 %) 0 (0 %) 0 (0 %) 1 (1 %, 0.9)
Pleuritis 2 (2 %) 1 (2 %) 0 (0 %) 1 (4 %) 1 (1 %, 0.8)
Lymphoid interstitial pneumonitis 2 (2 %) 0 (0 %) 1 (3 %) 1 (4 %) 1 (1 %, 0.7)
Lobar pneumonia 1 (1 %) 0 (0 %) 1 (3 %) 0 (0 %) 1 (1 %, 0.8)
Acute respiratory distress 1 (1 %) 1 (2 %) 0 (0 %) 0 (0 %) 3 (3 %, 1.5)
Pulmonary haemorrhage 1 (1 %) 1 (2 %) 0 (0 %) 0 (0 %) 1 (1 %, 0.7)
Normal lungs 10 (8 %) 9 (15 %) 0 (0 %) 1 (4 %) 9 (8 %, 2.4)
EPTB extrapulmonary tuberculosis, PTB pulmonary tuberculosis
Table 1 Comparison of age and sex distribution between study
and population deaths
Population (n = 3604)a Study (n = 121) Pb
Age (months)
Median (IQR) NA 19 (12–45) NA
<1 years 48.7 % (1787) 29 % (35) <0.001
1–4 years 36.7 % (1321) 48 % (58)
4–15 years 13.8 % (496) 23 % (28)
Male sex 50.2 % (1810) 64 % (77) 0.005
HIV infected 39.4 % (85/216)c 34 % (33/97)d 0.368
aAll inpatient deaths that did not take part in the study
bχ2 test
cHIV status of population estimated based on previous study [16]
dHIV status unavailable for 24 cases
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rifampicin resistance was detected (Table 5). The
‘PowerChek™ MTB/NTM Real-time PCR assay’ (Kogene,
South Korea) detected MTB in 6/10 (60 %) and NTM in
2/10 (20 %) of histopathologically confirmed TB cases.
Of the remaining two cases one was negative and the
other flagged as invalid (Table 4). Among non-TB cases,
the Kogene assay was positive for MTB in 6/111 (5 %)
and positive for NTM in 34/95 (39 %) cases, with 15
negatives (14 %) and 47 invalids (47 %). Running all
invalid samples again resulted in just one additional
NTM positive result. Comparing results of TB mo-
lecular analysis with lung pathology showed that mo-
lecular evidence of TB infection was readily detectable
in a range of cases with different pulmonary patholo-
gies (Table 5).
Discussion
Our study has four main findings, namely that (1) bron-
chopneumonia was the most prevalent lung pathology,
(2) comorbidity between non-communicable and com-
municable diseases was found in 80 % of children, (3)
tuberculosis was detected in 8 % of mortalities, with 9/
10 cases being undiagnosed and untreated ante mortem,
and (4) results of molecular analysis found evidence for
MTB in 7/10 histopathologically confirmed TB cases.
The results should be viewed in terms of several limi-
tations. Due to the generic social and resource limita-
tions of conducting full autopsies in any geographical
setting [11], our necropsy study had its focus on the
chest cavity and was limited by the small sample size
and the likelihood of the recruited children being older
Table 3 Comparison between lung pathology and diagnosis given by the attending physician
Lung pathology from post mortem
Attending physician diagnosis No lung
pathology
Any lung
pathology
Bronchopneumonia Interstitial
pneumonitis
Tuberculosis CMV
pneumonia
PCP
(n = 10) (n = 111) (n = 59) (n = 20) (n=10) (n = 8) (n = 6)
Communicable diseasesa
Pneumonia 20 % (2/10) 30 % (33/111) 31 % (18/59) 15 % (3/20) 40 % (4/10) 50 % (4/8) 50 % (3/6)
Sepsis/septic shock 40 % (4/10) 23 % (25/111) 22 % (13/59) 15 % (3/20) 20 % (2/10) 50 % (4/8) 17 % (1/6)
Acute diarrhoea and dehydration 40 % (4/10 23 % (26/111) 27 % (16/59) 35 % (7/20) 0 % (0/10) 25 % (2/8) 0 % (0/6)
Meningitis 30 % (3/10) 14 % (15/111) 8 % (5/59) 15 % (3/20) 30 % (3/10) 0 %(0/8) 17 % (1/6)
Tuberculosis 0 % (0/10) 8 % (9/111) 3 % (2/59) 5 % (1/20) 40 % (4/10) 13 % (1/8) 17 % (1/6)
Malaria 0 % (0/10) 5 % (5/111) 3 % (2/59) 15 % (3/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Typhoid/enteric fever 10 % (1/10) 3 % (3/111) 2 % (1/59) 5 % (1/20) 0 % (0/10) 0 % (0/8) 17 % (1/6)
PCP 0 % (0/10) 3 % (3/111) 3 % (2/59) 0 % (0/20) 0 % (0/10) 25 % (2/8) 17 % (1/6)
Hepatitis 0 % (0/10) 1 % (1/111) 2 % (1/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Tetanus 0 % (0/10) 1 % (1/111) 2 % (1/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Non-communicable diseasesb
Kwashiorkor/PEM, Marasmus
or PCM
40 % (4/10) 50 % (56/111) 53 % (31/59) 55 % (11/20) 80 % (8/10) 63 % (5/8) 33 % (2/6)
WAZ score < −2.0 (children
aged < 10 years old)
78 % (7/9) 63 % (57/91) 62 % (31/50) 56 % (9/16) 75 % (6/8) 63 % (5/8) 75 % (3/4)
Non-malnutrition 0 % (0/10) 14 % (15/111) 15 % (9/59) 10 % (2/20) 10 % (1/10) 0 % (0/8) 17 % (1/6)
Leukaemia 0 % (0/10) 1 % (1/111) 2 % (1/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Kaposi’s sarcoma 0 % (0/10) 2 % (2/111) 2 % (1/59) 0 % (0/20) 10 % (1/10) 0 % (0/8) 0 % (0/6)
Cerebral palsy 0 % (0/10) 3 % (3/111) 3 % (2/59) 5 % (1/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Congestive cardiac failure 0 % (0/10) 3 % (3/111) 3 % (2/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 17 % (1/6)
Rheumatic heart disease 0 % (0/10) 2 % (2/111) 3 % (2/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Sickle cell anaemia associated
cardiovascular accident
0 % (0/10) 1 % (1/111) 2 % (1/59) 0 % (0/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Primary immune deficiency 0 % (0/10) 1 % (1/111) 0 % (0/59) 5 % (1/20) 0 % (0/10) 0 % (0/8) 0 % (0/6)
Percentages indicate proportion of given lung pathology (columns) for which attending physician ascribed stated causes-of-death (rows)
aOther infectious causes-of-death without lung pathology: rabies (n = 1)
bNon-communicable disease causes-of-death with other lung pathologies not tabulated: Burkett’s lymphoma with pulmonary haemorrhage and pleural inflammation
(n= 1), hepatocellular carcinoma with pulmonary oedema (n= 1). Note: Causes-of-death and lung pathologies are not mutually exclusive
CMV cytomegalovirus, PCP pneumocystis Jirovecii pneumonia, PCM protein-calorie malnutrition, PEM protein energy malnutrition
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and male. These biases are difficult to avoid on a con-
senting autopsy study within a community that is
broadly culturally opposed to mutilation of the deceased
[10]. In addition to slightly lower reservations among
families over consenting for autopsy on males and older
children, the recruiting clinical officer (CC) felt that fam-
ilies of lower socioeconomic status were more likely to
consent, consistent with our recent adult autopsy study
[14], but we did not collect any socioeconomic indica-
tors such as maternal education status. Finally, the study
was undertaken at a referral centre and so does not in-
clude childhood deaths within the community. It should
be noted, however, that within Lusaka, referral systems
are well established and most childhood deaths occur at
UTH. The findings of this study should be interpreted in
light of these limitations.
The high prevalence of bacterial lung infections is
alarming, as these are supposedly treatable with the range
of antibiotics available at UTH, and more broadly within
Zambia and regionally. In addition, two thirds of pneumo-
nia cases were not diagnosed ante mortem. These deaths
could have been influenced by increasing levels of anti-
biotic resistance in common community acquired pneu-
monia pathogens such as Haemophilius influenzae and
Streptococcus pneumoniae [18]. Whilst susceptibility of
these two community acquired pneumonia pathogens to
front line antibiotics, such as Ampicillin and Amoxicillin,
remains quite high in Africa (70–90 %) [18], a mortality
Table 4 Molecular analysis of lung tissue from 10 histopathologically confirmed TB cases using Xpert MTB/RIF and PowerChek™
MTB/NTM Real-Time PCR assays
ID Age Sex HIV ATT ART ZN Xpert MTB/RIF Assay PowerChek™
MTB/NTM Assay
4B072 3 yr Female Positive No Yes Negative MTB (RIF sens) MTB
4B083 3 yr, 5 m Male Positive No Yes Positive MTB (RIF sens) MTB
4B008 2 yr, 7 m Female Negative No No Positive MTB (RIF sens) Invalid
4B036 10 yr Male Negative No No Negative Negative NTM
4B120 8 yr Female Positive No Yes Positive Negative NTM
4B055 1 yr, 5 m Male Negative No No Negative Negative MTB
4B064 10 yr Male Positive No Yes Positive Negative MTB
4B085 1 yr, 4 m Male Positive Yes Yes Negative Negative MTB
4B117 5 m Male Negative No No Negative Negative MTB
4B076 14 yr Female Unknown No No Negative Negative Negative
ATT anti-tuberculosis therapy, ART anti-retroviral therapy, MTB Mycobacterium tuberculosis, NTM non-TB mycobacteria, ZN Zeihl–Neelsen staining
Table 5 Prevalence of MTB detection by both Xpert MTB/RIF and PowerChek™ MTB/NTM Real-Time PCR assays, within groups with
specific lung pathologies
Xpert MTB/RIF Assay PowerChek™ MTB/NTM Assaya
MTB detected MTB detected NTM detected
Overall 30 % (36/121) 16 % (12/73) 62 % (45/73)
Lung pathology
Bronchopneumonia 30 % (18b/60) 9 % (3/35) 63 % (22/35)
Interstitial pneumonitis 60 % (8/20) 17 % (2/12) 67 % (8/12)
Tuberculosis (All forms) (PTB and/or EPTB) 30 % (3/10) 67 % (6/9) 22 % (2/9)
EPTB 100 % (1/1) 100 % (1/1) 0 % (0/1)
PTB 22 % (2/9) 63 % (5/8) 20 % (2/8)
Cytomegalovirus pneumonia 13 % (1/8) 0 % (0/4) 75 % (3/4)
Pneumocystis Jirovecii pneumonia 17 % (1/5) 0 % (0/3) 67 % (2/3)
Pulmonary oedema 33 % (2/6) 20 % (1/5) 80 % (4/5)
Candidiasis 0 % (0/3) 0 % (0/2) 50 % (1/2)
Acute respiratory distress 0 % (0/1) 0 % (0/1) 100 % (1/1)
Normal lungs 20 % (2/10) 0 % (0/7) 72 % (5/7)
aThe PowerChek™ MTB/NTM Assay gave an ‘invalid’ result in 48 lung tissue specimens, even after repeat analysis
bIncluding three rifampicin-resistant cases
EPTB extrapulmonary tuberculosis, MTB Mycobacterium tuberculosis, NTM non-TB mycobacteria, PTB pulmonary tuberculosis
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study naturally selects for severe infections that are more
likely to be drug resistant, present late or be complicated
by comorbidities. In the absence of full post mortem we
could not determine the relative contribution of lung
pathology with histopathological findings from other tis-
sues, but comparison of lung pathology findings with clin-
ical data identified possible comorbidity in up to 80 % of
cases. For a minority of cases with severe central nervous
system infections or congenital heart disease, the observed
lung pathology may have been secondary, but for the over-
whelming number of cases, including malnourished chil-
dren, the study pathologists (AS and VM) considered the
lung pathology observed to be the likely primary cause of
death. The observed high levels of comorbidity, in particu-
lar with malnutrition, are consistent with the high levels
of malnutrition in Zambia [19]. Severely malnourished
children are at increased risk of respiratory infections and
associated mortality [20].
Interstitial pneumonitis is defined as a thickening of
the interstitium, which damages alveoli architecture and
function [21]. It can be caused by bacterial, viral or fun-
gal lung infections, and also has a range of non-
infectious aetiologies such as air pollutants. In poor
communities in urban Zambia, most cooking is done on
charcoal [22]. As the second most prevalent cause of
fatal lung pathology, observed in 17 % (20/121) of cases,
the aetiology of interstitial pneumonitis in African children
requires further definition, possibly through immunocyto-
chemistry or next generation sequencing of tissue speci-
mens. It is challenging to establish a definitive diagnosis
ante mortem, with chest x-ray manifestations having con-
siderable overlap with other lung diseases such as TB [7].
Histopathologically confirmed TB (observation of
granulomas, caseous necrosis and Langhans giant cells)
was detected in 8 % (10/121) of cases. Molecular analysis
confirmed the presence of M.tb DNA in 7/10 cases, and
evidenced possible NTM infection in two cases. A recent
national study determined the prevalence of symptom-
atic NTM infection in Zambian adults to be three-fold
higher than the national TB prevalence [23], which sug-
gests NTM infections could also be a significant cause
of disease in children as reviewed [24]. M.tb and NTM
specific DNA was also commonly detected in the ab-
sence of histopathological evidence of TB infection, pos-
sibly indicative of latent infections, including three cases
with rifampicin resistance or comorbidity where less se-
vere TB/NTM infection was secondary to bronchopneu-
monia or other causes of death.
These findings seem at odds with Global Burden of
Disease estimates, which do not consider TB as a not-
able cause of death in African children [25]. However,
they are consistent with the views of other leading com-
mentators [26–28] and our previous paediatric autopsy
study (conducted between 1997–2000) which confirmed
TB as a cause of death in 20 % (54/264) of cases, with the
point prevalence being higher among HIV-uninfected
children (26 %) than among HIV-infected children (18 %)
[12]. Similarly in this study, we found TB in both HIV-
infected and uninfected children. In Zambia, childhood
TB notification rates have fallen over the last decade [29],
but TB clearly remains an important cause of death. Im-
portantly, only 10 % (1/10) of TB cases were on TB treat-
ment when they died, illustrating how poor TB diagnostic
services are for children at UTH. Despite significant im-
provements in HIV prevention, diagnosis and treatment
over the last decade [30], it is the slow pace of improve-
ments in TB diagnostic tools and services for children
[31] that has allowed TB to persist as a significant cause of
death in children. A recent modelling study suggested
that, for 15 high burden countries, only 35 % of incident
paediatric TB cases are notified globally [26].
Malnutrition was observed in 80 % of histopathologic-
ally confirmed TB cases. The mortality rate on the mal-
nutrition ward within the department of paediatrics and
child health at UTH is 18 %, second highest only to the
neonatal intensive care unit (30–50 %) [32]. More active
surveillance of TB and bacterial pneumonia may be jus-
tified in malnourished paediatric admissions, and among
malnourished children with TB contact, attending com-
munity clinics, at high risk of referral to UTH. There is
maybe reservation to conduct invasive sampling in se-
verely malnourished children, as it may be unpleasant
for the patient. As they are on antibiotics to cover bac-
terial lung or gut infections and PCP, the main focus is
on addressing their nutritional needs. This might mean
that TB or viral respiratory infections are overlooked.
The ideal specimen for TB diagnosis in young children
is induced sputum [33] but spent feeding tubes could be
considered as a non-additionally invasive source of gas-
tric aspirate for TB analysis in severely ill malnourished
children [16].
The point prevalence of CMV pneumonia (7 %) and
PCP (5 %) were both lower than previously reported
[12], contrary to our previous study where, with a larger
sample, we saw a strong association with HIV infection
(CMV = 22 %, PCP = 29 %). The previous study was
undertaken prior to paediatric ART roll-out in Zambia
and prior to the implementation of cotrimoxazole
prophylaxis in HIV-infected children with pneumonia
[12], which may have impacted on reducing CMV and
PCP-associated deaths in HIV-infected children. The
previous study also included only respiratory mortalities,
had a lower median age, and used both immunocyto-
chemistry as well as the observation of classic ‘owls eye’
inclusions to define CMV infection [12]. We have
shown, in a recent population-based study [34], that
early infant CMV infections are linked with impaired de-
velopment of Zambian infants and, that among admitted
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infants, CMV DNAemia is associated with being under-
weight, meningitis, and HIV infection [35], suggesting
CMV is an important determinant of health in African
children. CMV pneumonia is currently treated with
intravenous Ganciclovir at some centres in South Africa
[36–38]. CMV was not considered ante mortem because
Ganciclovir is not currently available at UTH, can cause
leukopenia and neutropenia [39], and could be harmful
in some HIV-infected children with a low CD4. There is
a need for controlled trials for anti-CMV drugs in the
African paediatric setting [36, 40].
Conclusions
The high level of discrepancy between clinical diagnoses
and post mortem findings is alarming but is consistent
with previous adult autopsy studies undertaken in Africa
[14, 41–45], and in many cases is suggestive that patients
were not receiving optimal care. Whilst some undiag-
nosed infections may be captured by empirical broad-
spectrum antibiotic therapy, important pathogens such
as TB and CMV were undiagnosed and untreated in most
cases. The high burden of bacterial pneumonia despite the
availability of a broad panel of antibiotics raises questions
over levels of drug-resistant bacterial lung infections
among paediatric admissions and management of children
with comorbidities. Interstitial pneumonitis is a common
cause of death and its precise aetiology in African children
requires further definition. TB is not considered a signifi-
cant cause of death among children by the broader global
health community [1, 25], but our demonstration of the
importance of TB as a cause of death in Zambian children,
first in 2002 [12] and now again over a decade later, sup-
ported by molecular analysis, suggests that more intensi-
fied TB case finding among children is needed at all levels
of healthcare, with a particular focus on malnourished
children. UTH and other hospitals serving high TB bur-
den urban communities in sub-Saharan Africa might want
to consider piloting intensified TB case finding among
malnourished paediatric admissions.
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